GlassScriptPhysician profile
Ariel A Schnell
NPI 1881246502
$1,071.97
in general payments reported to CMS, 2019-2025
9 companies · $27.33 in 2025
The $27.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.45 · 2022: $360 · 2023: $485 · 2024: $149 · 2025: $27.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $271.04 | 2023-2024 | Repatha |
| Janssen Scientific Affairs, LLC | $158.54 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.78 | 2023 | |
| Nxstage Medical, INC. | $114.84 | 2022-2023 | Nxstage System One |
| Medtronic, INC. | $104.32 | 2022 | |
| Vifor Pharma, INC. | $97.69 | 2022 | |
| Novo Nordisk INC | $50.45 | 2021 | |
| Edwards Lifesciences Corporation | $27.33 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Schnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.